MARIAN MARSH: Open Payments
NPI 1770733560 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 16 payments from 6 companies in 2025. Trend: 2023 $189 · 2024 $226 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $206 |
| ACADIA Pharmaceuticals Inc | 3 | $67 |
| TG Therapeutics, Inc. | 2 | $42 |
| Janssen Biotech, Inc. | 1 | $24 |
| Neurelis, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: UBRELVY, QULIPTA, NUPLAZID, BOTOX, BRIUMVI, VALTOCO, Symbravo.
Industry payments across ID — which companies pay providers there.
